Literature DB >> 7614184

Use of computer-assisted image analysis for noninvasive evaluation of oral lichenoid reactions and oral leukoplakia.

U Mattsson1, A Chodorowski, T Gustavsson, G Heyden, M Jontell, F Bergquist.   

Abstract

The objective of the present study was to elaborate and to evaluate a method in which the clinical appearance of a mucosal lesion could be expressed by means of color and morphologic features extracted from digitized images. The ability to express mucosal changes with image features was evaluated, as was the accuracy of a classification of the lesions on the basis of image feature analysis. Computer-assisted image analysis was performed on digitized color slides from 76 patients with lichenoid reactions that included both oral lichen planus and contact lesions and 20 patients with homogenous oral leukoplakia. Color features were measured according to the intensity-hue-saturation color system, and morphologic features were estimated by tracing the hyperkeratotic area. Hyperkeratinizing and inflammatory tissue reactions could be demonstrated and defined by image analysis. Image features indicating inflammatory tissue reactions were more pronounced in cases of oral lichenoid reactions. Morphologic parameters could express the anatomic appearance of the lesions. The comparison between histopathologic diagnosis and a classification through computerized analysis demonstrated that 90.5% of oral lichenoid reactions could be separated from homogenous oral leukoplakia by linear discriminant analysis.

Entities:  

Mesh:

Year:  1995        PMID: 7614184     DOI: 10.1016/s1079-2104(05)80282-3

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod        ISSN: 1079-2104


  1 in total

1.  Correlation analysis of oral lesion sizes by various standardized criteria.

Authors:  Carrie E Flanagan; Nelson L Rhodus; Kate A Cole; Eva Szabo; Frank G Ondrey
Journal:  Am J Otolaryngol       Date:  2016-07-12       Impact factor: 1.808

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.